Augustina Isioma Ikusemoro: ABO Discrepancies in Transfusion Practice
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Abo Discrepancies: When Blood Groups Don’t Behave the Way We Expect
Every transfusion professional has faced that moment:
Forward group says one thing.
Reverse group says another.
And the results don’t match.
That’s an Abo discrepancy – and recognizing its type can make the difference between safe transfusion practice and serious clinical risk.
Why Abo discrepancy recognition matters
Because transfusion safety begins before the blood leaves the blood bank.
Every discrepancy resolved correctly protects:
- trauma patients
- oncology patients
- neonates
- transplant recipients
- and every life that depends on accurate compatibility testing.
In transfusion medicine, details save lives.
If you’re working in a blood bank or transfusion service, tell me:
Which type of Abo discrepancy do you encounter most often in your practice?
Blood Doki, Blood Knowledge, Saving lives.”
Stay updated with Hemostasis Today.
-
Sep 22, 2026, 19:02Blocking Histone-Induced Platelet-Erythrocyte Interactions With Polyanions – Platelets Journal
-
Sep 22, 2026, 18:49Abdul Rahman Hamad: Early Action for Better Outcomes in Deep Vein Thrombosis
-
Sep 22, 2026, 18:37Carmine Siniscalchi: Age-Adjusted D-Dimer Cutoffs in DVT Diagnosis
-
Sep 22, 2026, 18:37Stefano Romeo: The Cardiovascular Patient Journey is Still Full of Gaps
-
Sep 22, 2026, 18:11Bharath Kumar V.։ Advancing Safer Anticoagulation for Cancer-Associated Thrombosis
-
Sep 22, 2026, 18:10Fatima Zahra: ASH Released New Guidelines on the Diagnosis of Iron Deficiency
-
Sep 22, 2026, 17:49Nirav Dhanesha: Targeting FXI for Safer Anticoagulation
-
Sep 22, 2026, 17:17Eric Lambert: Intravascular Imaging and the Future of Precision PCI
-
Sep 22, 2026, 16:45Claudiu Stoicescu: Are We Starting Cardiovascular Risk Assessment Too Late?